Guillain-Barré Syndrome: Natural history and prognostic factors: A retrospective review of 106 cases

BMC Neurology

Volumn 13, Issue , 2013, Pages

  González Suárez, Inés ^a   Sanz Gallego, Irene ^a   Rodríguez de Rivera, Francisco Javier ^a   Arpa, Javier ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Guillain Barre; Natural history; Peak flow; Prognostic factors

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CRANIAL NERVE INJURY; DISEASE SEVERITY; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; AGED; AXON; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RESPIRATORY FAILURE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AXONS; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MIDDLE AGED; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84880335749     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-95     Document Type: Article

References (35)

1. Van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 2008, 7:939-950. 10.1016/S1474-4422(08)70215-1, 18848313.
2. Vucic S, Kiernan MC, Cornblath DR. Guillain-Barré syndrome: An update. J Cli Neurosci 2009, 16:733-741.
3. Tellería-Díaz A, Calzada-Sierra DJ. Síndrome de Guillain-Barré. Rev Neurol 2002, 34(10):966-976.
4. Asbury AK, Arnason BGW, Karp HR, McFarlin DF. Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol 1978, 3:565-566.
5. Asbury AK, Cornblath DR. Assesment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990, 27(Suppl):S21-S24.
6. Hughes RAC, Rees JH. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 1997, 176(suppl2):S92-S98.
7. Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011, 29:599-612. 10.1016/j.vaccine.2010.06.003, 20600491.
8. McGrogan A, Madle G, Seaman HE, De Vries CS. The epidemiology of Guillain-Barré syndrome worldwide. Neuroepidemiology 2009, 32:150-163. 10.1159/000184748, 19088488.
9. The Emilia-Romagna Study group on Clinical and Epidemiological Problems in Neurology A prospective study on the incidence and prognosis of Guillain-Barré syndrome in Emilia-Romagna region, Italy (1992-1993). Neurology 1997, 48:214-221. The Emilia-Romagna Study group on Clinical and Epidemiological Problems in Neurology.
10. Lyu R-K, Tang L-M, Cheng S-Y, Hsa W-C, Chen S-T. Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurgery Psychiatry 1997, 63:494-500.
11. Cuadrado JI, de Pedro Cuesta J, Ara JR, Cemillan CA, Díaz M, Duarte J, et al. Guillain-Barré syndrome in Spain, 1985-1997: epidemiological and public health view. Eur Neurol 2001, 46:83-91. 10.1159/000050769, 11528157.
12. Alandro-Benito Y, Conde-Sendín MA, Muñoz-Fernández C, Pérez-Correa S, Alemany-Rodríguez MJ, Fiuza-Pérez MD, et al. Síndrome de Guillain-Barré en el área norte de Gran Canaria e isla de Lanzarote. Rev Neurol (Barc.) 2002, 35:705-710.
13. Soysal A, Aysal F, Caliskan B, Dogan Ak P, Mutluay B, Sakalli N, et al. Clinico-electrophysiological findings and prognosis of Guillain-Barré syndrome - 10 years'experience. Acta Neurol Scand 2011, 123:181-186. 10.1111/j.1600-0404.2010.01366.x, 20497128.
14. The Italian Guillain-Barré Study Group The prognosis and main prognostic indicators of GuillainBarré syndrome. A multicentre prospective study of 297 patients. Brain 1996, 119:2053-2061. The Italian Guillain-Barré Study Group.
15. Van Koningsveld R, Steyerberg EW, Hughes RAC, Swan AV, Van Doorn PA, Jacobs BC. A clinical prognostic scoring system of Guillain-Barré syndrome. Lancet Neurol 2007, 6:589-594. 10.1016/S1474-4422(07)70130-8, 17537676.
16. Chodwury D, Arora A. Axonal Guillain Barré syndrome: a critical review. Acta Neurol Scand 2001, 103:267-277.
17. Mori M, Kuwaraba S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001, 56:1104-1106. 10.1212/WNL.56.8.1104, 11320188.
18. Korinthenberg R, Schessl J, Kirschner J. Clinical presentation and course of childhood Guillain-Barré syndrome: a prospective multicentre study. Neuropediatrics 2007, 38:10-17. 10.1055/s-2007-981686, 17607598.
19. Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol 2001, 58:871-872. 10.1001/archneur.58.6.871, 11405800.
20. Durand MC, Porcher R, Orlikowski D, Aboab J, Devaux C, Clair B, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study. Lancet Neurol 2006, 5:1021-1028. 10.1016/S1474-4422(06)70603-2, 17110282.
21. Guillain- Barré syndrome 1991, Philadelphia: F.A. Davis, Ropper AH, Widjicks EFM, Truax BT.
22. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polineuropathy. Lancet 1978, 2:750-753.
23. Hadden RDM, Cornblath DR, Hughes RAC, Zielasek J, Hartung HP, Toyka K, et al. Electrophysiological classification of Guillain-Barré Syndrome: clinical associations and outcome. Ann Neurol 1998, 44:780-788. 10.1002/ana.410440512, 9818934.
24. Hughes RAC, Cornblath DR. Guillain-Barré syndrome. Lancet Neurol 2005, 366:1653-1666.
25. Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology 2001, 56:758-765. 10.1212/WNL.56.6.758, 11274311.
26. Saifudheen K, Jose J, Gafoor VA, Musthafa M. Guillain-Barré síndrome and SIADH. Neurology 2011, 76:701-704. 10.1212/WNL.0b013e31820d8b40, 21339497.
27. Van den Bergh PYK, Piéret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004, 29:565-574. 10.1002/mus.20022, 15052622.
28. Vucic S, Cairns KD, Black KR, Chong PST, Cros D. Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy. Clin Neurophysiology 2004, 115:2329-2335.
29. Alam TA, Chaudhry V, Cornblath DR, Alam TA, Chaudhry V, Cornblath DR. Electrophysiological studies in the Guillain-Barré syndrome: 30 Electrophysiological studies in the Guillain-Barré syndrome: distinguishing subtypes by published criteria. Muscle Nerve 1998, 21:1275-1279. 10.1002/(SICI)1097-4598(199810)21:10<1275::AID-MUS5>3.0.CO;2-8, 9736055, Electrophysiological studies in the Guillain-Barré syndrome: 30.
30. Jamal GA, Leod Mac WN. Electrophysiologic studies in Miller Fisher syndrome. Neurology 1984, 34:685-688. 10.1212/WNL.34.5.685, 6538663.
31. Lo YL. Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve 2007, 36:615-627. 10.1002/mus.20835, 17657801.
32. Yuki N. Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome). J Neuroimmunol 2009, 215:1-9. 10.1016/j.jneuroim.2009.05.020, 19643503.
33. Rajabally YA, Unicini A. Outcome and its predictors in Guillain-barré syndrome. J Neurol Neurosurg Psychiatry 2012, 83:711-718. 10.1136/jnnp-2011-301882, 22566597.
34. Walgaard C, Lingsma HF, Ruts L, et al. Early recognition of poor prognosis in Guillain-Barré syndrome. Neurology 2011, 76:968-975. 10.1212/WNL.0b013e3182104407, 3059137, 21403108.
35. Suarez AA, Pessolano FA, Monteiro SG, Ferreyra G, Capria ME, Mesa L, et al. Peak flow and peak cough flow in the evaluation of expiratory muscle weakness and bulbar impairment in patients with neuromuscular disease. Am J Phys Med Rehabil 2002, 81:506-511. 10.1097/00002060-200207000-00007, 12131177.